Page last updated: 2024-08-16

salmeterol xinafoate and alpha 1-Antitrypsin Deficiency

salmeterol xinafoate has been researched along with alpha 1-Antitrypsin Deficiency in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertella, E; Boni, E; Corda, L; La Piana, GE; Redolfi, S; Tantucci, C1

Trials

1 trial(s) available for salmeterol xinafoate and alpha 1-Antitrypsin Deficiency

ArticleYear
Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
    Respiration; international review of thoracic diseases, 2008, Volume: 76, Issue:1

    Topics: Administration, Inhalation; Aged; Albuterol; alpha 1-Antitrypsin Deficiency; Beclomethasone; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Dyspnea; Exercise Tolerance; Female; Glucocorticoids; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Salmeterol Xinafoate; Scopolamine Derivatives

2008